Steinkasserer; Alexander

Patent Applications and Registrations

Patent applications and USPTO patent grants for Steinkasserer; Alexander.The latest application filed is for "use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases".

Company Profile

0.10.9

Steinkasserer; Alexander - Marloffstein N/A DE
Steinkasserer; Alexander - Bruckenhof N/A DE
Steinkasserer; Alexander - Erlangen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mutant CD83 promoter and use thereof Grant 9,822,377 - Steinkasserer , et al. November 21, 2	2017-11-21
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases Grant 9,732,140 - Steinkasserer , et al. August 15, 2	2017-08-15
Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same Grant 9,102,726 - Steinkasserer , et al. August 11, 2	2015-08-11
Use Of Soluble Forms Of Cd83 And Nucleic Acids Encoding Them For The Treatment Or Prevention Of Diseases App 20150065684 - STEINKASSERER; ALEXANDER ; et al.	2015-03-05
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases Grant 8,759,505 - Steinkasserer , et al. June 24, 2	2014-06-24
Mutant Cd83 Promoter And Use Thereof App 20140050748 - Steinkasserer; Alexander ; et al.	2014-02-20
Method For Inhibiting The Maturation Of Dendritic Cells App 20120269797 - Schubert; Ulrich ; et al.	2012-10-25
Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells Grant 8,124,099 - Steinkasserer , et al. February 28, 2	2012-02-28
Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases App 20120015890 - STEINKASSERER; Alexander ; et al.	2012-01-19
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases Grant 7,893,200 - Steinkasserer , et al. February 22, 2	2011-02-22
Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells App 20070212370 - Steinkasserer; Alexander ; et al.	2007-09-13
Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases App 20070167607 - Steinkasserer; Alexander ; et al.	2007-07-19
Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells Grant 7,169,898 - Steinkasserer , et al. January 30, 2	2007-01-30
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases App 20040116338 - Steinkasserer, Alexander ; et al.	2004-06-17
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases App 20040110673 - Steinkasserer, Alexander ; et al.	2004-06-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.